Total
0
Shares
Source: Nanoveu
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Nanotechnology company Nanoveu (NVU) receives patent cooperation treaty approval for EyeFyx
  • The patent secures intellectual property rights in multiple markets including Australia, Japan, Europe, China, the UK and the USA
  • EyeFyx provides vision correction for screen images and helps people suffering from farsightedness view images and text on digital screens without glasses
  • Nanoveu is now in the process of investigating opportunities to commercialise the technology
  • Nanoveu closed 7.32 per cent in the red on Thursday, with shares trading at 3.8 cents each

Nanotechnology company Nanoveu (NVU) has received patent cooperation treaty approval for EyeFyx.

The patent secures intellectual property rights in multiple markets including Australia, Japan, Europe, China, the UK and the USA.

EyeFyx provides vision correction for screen images via a film that is printed with different nano-lens structures.

The technology uses nano-imprinting lithography (NIL) to produce a thin-film lens that can be applied to select digital devices.

It’s then combined with an embedded software that renders clear images onto the retina of a person with blurred vision.

With the use of EyeFyx, people suffering from presbyopia, or farsightedness, are able to view images and text on digital screens without reading glasses.

Presbyopia is the gradual loss of the eyes’ ability to focus on nearby objects.

It is a normal occurrence with ageing and typically become more noticeable in middle age and continues to deteriorate with age.

“We are very excited for Nanoveu to be granted patent cooperation treaty approval for EyeFyx, as it represents one of the next steps in the commercialisation process,” CEO Alfred Chong said.

“A significant market exists for EyeFyx and we now look forward to advancing commercial discussions with interested parties globally.”

Nanoveu is now in the process of investigating opportunities to commercialise the technology.

Nanoveu closed 7.32 per cent in the red on Thursday, with shares trading at 3.8 cents each.

NVU by the numbers
More From The Market Herald
Advanced Human Imaging (ASX:AHI) - CEO, Vlado Bosanac

" Advanced Human Imaging (ASX:AHI) advances Meta-Twin for digital health assessments

Advanced Human Imaging (AHI) has announced the advancement of its Meta-Twin offering, a real-time, on-screen digital health assessment.
The Market Herald Video

" Security Matters (ASX:SMX): Addressing fashion’s $40-billion problem

Australian company Security Matters is taking the lead in helping the fashion industry’s attempts to address a $40-billion problem.
Adriatic Metals PLC (ASX:ADT) - CEO, Paul Cronin

" Adriatic Metals (ASX:ADT) releases silver assays for Rupice Mineral Resource

Adriatic Metals (ADT) has released silver assays for its wholly-owned Vares Silver Project in Bosnia and Herzegovina.
Turaco Gold (ASX:TCG) -Managing Director, Justin Tremain

" Turaco Gold (ASX:TCG) receives results from Bouake North

Turaco Gold (TCG) has received results from its recently completed auger drilling program at the Bouake North prospect in Côte d’Ivoire.